Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) 40 mg Suppliers & Bulk Manufacturers
Available Forms: Prefilled syringe
Available Strengths: 40 mg
Reference Brands: Generic formulations
Category: R&D
Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) is a R&D product available as Prefilled syringe in strengths 40 mg. It corresponds to the reference brand Generic formulations. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Tirzepatide 40 mg is a synthetic peptide used in research and laboratory studies focused on diabetes and weight management. It acts as a dual GIP and GLP-1 receptor agonist, making it valuable for investigational studies on metabolic regulation. For research and laboratory use only.
Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) — third party manufacturing & bulk supply
Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) is supplied as Prefilled syringe — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tirzepatide 40Mg Pen Device With Cartridge Box (R&D Only) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Tirzepatide 40Mg Pen Device With Cartri... →Frequently Asked Questions
Tirzepatide 40 mg is used in research and laboratory studies related to metabolic disorders, including diabetes and weight management mechanisms. It is commonly utilized in investigational and formulation research settings to study dual GIP and GLP-1 receptor activity.
Tirzepatide 40 mg is made from the active peptide compound tirzepatide, a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Tirzepatide 40 mg does not have a trade name, as it is marketed and referred to only by its generic name.
Tirzepatide 40 mg is manufactured by Shilai Healthcare.
The generic name of the product is tirzepatide.
There is no brand name associated with this product. It is available only as a generic formulation.
Tirzepatide 40 mg is manufactured by Shilai Healthcare.
Related Products
Ghk-Cu 50 Mg, Bpc-157 Pen Device With Cartridge Box (R&D Only)
Strength:
70 mg
Form: Prefilled syringe
Reference Brands: Klow Blend
View Details
Nad⁺ 1000 Mg Pen Device With Cartridge Box (R&D Only)
Strength:
1000 mg
Form: Prefilled syringe
Reference Brands: Generic formulations
View Details
Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only)
Strength:
10 mg + 10 mg
Form: Prefilled syringe
Reference Brands: Generic formulations
View Details
Ghk-Cu 100Mg Pen Device With Cartridge Box (R&D Only)
Strength:
100 mg
Form: Prefilled syringe
Reference Brands: Generic formulations
View Details
Retatrutide 40 Mg Pen With Cartridge Box (R&D Only)
Strength:
40 mg
Form: Prefilled syringe
Reference Brands: Generic formulations
View Details
Retatrutide Injection (R&D Only)
Strength:
40 mg
Form: Injection
Reference Brands: Generic formulations
View Details
Ghk-Cu Injection 70 Mg (R&D Only)
Strength:
70 mg
Form: Injection
Reference Brands: Glow 70mg
View Details
Nad⁺ 500Mg Injection (R&D Only)
Strength:
500 mg
Form: Injection
Reference Brands: Generic formulations
View DetailsQuick Response Guaranteed | Verified Suppliers
